Babaoğlu, M. Ö. Et Al. 2003. Losartan as a probe for phenotyping of CYP2C9 in Turkish population. Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics , (İstanbul, Turkey).

Babaoğlu, M. Ö., YAŞAR, Ü., DİNÇEL, A., Eliasson, E., Dahl, M., & BOZKURT, A., (2003). Losartan as a probe for phenotyping of CYP2C9 in Turkish population . Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics, İstanbul, Turkey

Babaoğlu, Melih Et Al. "Losartan as a probe for phenotyping of CYP2C9 in Turkish population," Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics, İstanbul, Turkey, 2003

Babaoğlu, Melih Ö. Et Al. "Losartan as a probe for phenotyping of CYP2C9 in Turkish population." Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics , İstanbul, Turkey, 2003

Babaoğlu, M. Ö. Et Al. (2003) . "Losartan as a probe for phenotyping of CYP2C9 in Turkish population." Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics , İstanbul, Turkey.

@conferencepaper{conferencepaper, author={Melih Ö. Babaoğlu Et Al. }, title={Losartan as a probe for phenotyping of CYP2C9 in Turkish population}, congress name={Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics}, city={İstanbul}, country={Turkey}, year={2003}}